Faecal microbiota signature for pancreatic cancer

Patent number:

WO2023/052486 (A1)

Comunidad de Madrid.svg
No items found.

The inventors have found a method for early diagnosing pancreatic cancer based on a faecal microbiota signature with high specificity for pancreatic cancer.

Countries:
Spain
Regions:
Community of Madrid
Centers:
SPANISH NATIONAL CANCER RESEARCH CENTRE, CENTRO NACIONAL DE INVESTIGACEIONES ONCOLOGICAS CNIO
Other entities:
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The method of the invention is a sensitive, specific and non-invasive method for an early detection of pancreatic cancer, in particular Pancreatic Ductal Adenocarcinoma (PDAC) that could therefore improve survival outcomes. The present invention refers to a method for diagnosing pancreatic cancer in a subject comprising determining the abundance of several Microbiome species in a faecal sample from said subject, as well as to a kit and its use for the diagnosis of pancreatic cancer.

Comments

Other related patents

New & Sustainable Materials
Health

3D printing device and 3D printing method

Countries
Spain
Know more
Health

360 DEGREES AUDIOLOGICAL TEST SYSTEM USING VIRTUAL LOUDSPEAKERS (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries
Spain
Know more
Health

SALTS OF PYRIDAZINO[2,3-A]PYRROLO[2,1-C]QUINOXALINE FOR THE TREATMENT OF LEISHMANIA INFECTIONS AND DISEASES THAT INVOLVE THE PROTEIN TYROSINE PHOSPHATASE 1B

Countries
Spain
Know more
Get back to patents directory